Analyst Ratings for TCR2 Therapeutics (TCRR) [Buys]
TCRR Rating Summary
TCRR Price Target Summary
- Highest: $10.00 (Piper Sandler)
- Lowest: $1.72 (Mizuho Securities)
- Average: $3.95
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$3.95 (+163.6%)
* Over Last 12-Mos
Rating Score: 2.7 / 10
Percentile Rank: 22%
Rating Score: 2.7 / 10
Percentile Rank: 22%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/19/2021 | Piper Sandler » Updated 1/6/2023 |
Do Kim | New Coverage | Overweight (N/A) |
10.00 (8.00) |
6.60 (1.50) |
-77.27% | Details |
| 7/27/2020 | Roth/MKM | Tony Butler | Upgrade | Buy (Neutral) |
35.00 (N/A) |
13.10 (1.50) |
-88.55% | Details |
 |
||||||||
